‪New trial shows triheptanoin may treat rare neurodegenerative disease A-T & flags biomarkers to track. Thanks to UQ, @griffith.edu.au & more. Now in @ebiomedicine.bsky.social 🧪 redenlab.com/phase-2a-b-randomised-placebo-controlled-dose-escalation-trial-of-triheptanoin-for-ataxia-telangiectasia/